MRT isotopes

Question 1

Lu-177 Dotatate

Answer 1

Approved for clinical dosimetry, tradename Lutathera. For NET

Question 2

Lu-177 PSMA

Answer 2

Approved for clinical dosimetry, Pluvicto tradename. For castrate resistant prostate CA.

Question 3

I-131 NaI

Answer 3

Approved for clinical dosimetry, I-131 Sodium Iodide. For Thyroid CA.

Question 4

I-131 MIBG

Answer 4

Approved for clinical dosimetry, Azedra tradename. For Neuroblastoma, pheochromocytoma + paraganglioma

Question 5

Y-90

Answer 5

Not approved for clinical dosimetry. Kernel exists for research in MIM. For NETs

Question 6

Ra-223-dichloride

Answer 6

Therapy is approved but as alpha emitter this is a research feature in MIM. Tradename Xofigo. For metastatic castration-resistant prostate cancer with bone mets but no visceral mets

Question 7

Cu-67

Answer 7

Not approved for clinical dosimetry. Kernel exists for research in MIM. For NETs

Question 8

Ac-225-PSMA

Answer 8

Not approved for clinical dosimetry. Kernel exists for research in MIM. For metastatic castrat- resistant prostate CA. Alpha Emitter

Question 9

Ac-225-DOTATOC

Answer 9

Not approved for clinical dosimetry. Kernel exists for research in MIM. For NETs. Alpha emitter

Question 10

Pb-212

Answer 10

Not approved for clinical dosimetry. Kernel exists for research in MIM. Delivers alpha particle radiation for PSMA or SSRT. Decays to alpha Bi-212.

Question 11

Lu-177-DOTATOC

Answer 11

Approved for clinical dosimetry. For NETs

Question 12

Ga-68-DOTATATE

Answer 12

PET tracer, Pre-Therapy planning for Lu177 Dotatate. Kernel available in MIM.

Question 13

I-124

Answer 13

PET tracer, Pre-Therapy planning for I131 NaI. Kernel available in MIM.

Question 14

Cu-64-DOTATATE

Answer 14

PET tracer, surrogate for Lu177 Dotatate or Pre- therapy planing for Cu67 Dotatate. Kernel available in MIM. Better planning tracer than G-68 due to the longer half life.

Question 15

F-18-PSMA

Answer 15

PET tracer, Pre-therapy planning for PSMA. Kernel available in MIM.

Question 16

Ga-68-PSMA

Answer 16

PET tracer, Pre-therapy planning for PSMA. Kernel available in MIM.

Question 17

Zr-89

Answer 17

PET tracer, surrogate planning for Lu177 Dotatate. Kernel available in MIM.

Question 18

Pb-203

Answer 18

SPECT tracer, theranostic pair for Pb212. Hidden reasearch feature available in MIM. Residence times only.

Question 19

In-111

Answer 19

SPECT tracer, co-administered with Y90 for SPECT visualization and surrogate dosimetry. Kernel available in MIM.

Question 20

Ga-67

Answer 20

SPECT tracer. Kernel available in MIM

Question 21

I-123

Answer 21

SPECT tracer. Kernel available in MIM

Question 22

Tc99m

Answer 22

SPECT tracer. Kernel available in MIM

Question 23

Re-186 HDP

Answer 23

Therapy for palliative pain from bone mets. Hidden research feature and kernel available in MIM.

Question 24

Re-188 HDP

Answer 24

Therapy for palliative pain from bone mets. Hidden research feature and kernel available in MIM.

Question 25

Sm-153 MDP

Answer 25

Therapy for palliative pain from bone mets. Hidden research feature and kernel available in MIM.

Question 26

Sr-89

Answer 26

Therapy for palliative pain from bone mets. Hidden research feature and kernal available in MIM.

Question 27

Sn-117m

Answer 27

Therapy for palliative pain from bone mets. Hidden research feature and kernel available in MIM.